A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer

Part of paid clinical trials in Chicago, Illinois.

Sponsor
University of Chicago
Study ID
NCT03729115
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
25 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Magnetic Resonance Imaging (MRI) — PROCEDURE
    Patients will have MRI scans every 6 months.

Study Details

This study is aimed to establish a registry of women undergoing intensive surveillance for the early detection of breast cancer in high-risk women.

Key Dates

Start date
May 30, 2019
Status verified
Sep 2025
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
400 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING

Arms

  • Other: Screening Arm
    Enrolled patients will undergo Magnetic Resonance Imaging (MRI) every 6 months (2x/year) in addition to an annual screening mammogram.

Primary Outcome Measure

Development of faster MRI protocols for a for a Personalized Risk-based Imaging Surveillance Model for diverse populations of high risk women. [ Time Frame: 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University Of Chicago Medicine Comprehensive Cancer CenterChicagoIllinois60637
Cancer Clinical Trials Intake
[email protected]
1-855-702-8222
Olufunmilayo Olopade, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Chicago, IL

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
University Of Chicago Medicine Comprehensive Cancer Center· Chicago, IL

Related Studies